ARTICLE | Company News
Certara, Critical Path Institute deal
September 16, 2013 7:00 AM UTC
Certara partnered with Critical Path Institute (C-Path) to develop a physiology-based pharmacokinetic model of the human lung, which will help researchers test new tuberculosis (TB) drugs. The model w...